LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
about
A role for the ubiquitin ligase Nedd4 in membrane sorting of LAPTM4 proteins.LAPTM4B allele *2 is a marker of poor prognosis following hepatic tumor resection for hepatocellular carcinoma.LAPTM4B allele *2 is associated with breast cancer susceptibility and prognosis.LAPTM4B allele *2 is a marker of poor prognosis for gallbladder carcinomaLysosomal-associated protein transmembrane 4 Beta-35 overexpression is a novel independent prognostic marker for gastric carcinoma.Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer.Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor β1 (TGF-β1) Production in Human Regulatory T Cells.Migration-inducing gene 7 promotes tumorigenesis and angiogenesis and independently predicts poor prognosis of epithelial ovarian cancer.Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer.LAPTM4B: an oncogene in various solid tumors and its functions.Overexpressed LAPTM4B-35 is a risk factor for cancer recurrence and poor prognosis in non-small-cell lung cancer.Transforming growth factor β-activated kinase 1 inhibitor suppresses the proliferation in triple-negative breast cancer through TGF-β/TGFR pathway.Lentivirus-mediated RNA Interference Targeting LAPTM4B Inhibits Human Ovarian Cancer Cell Invasion In Vitro.Expression levels and clinical significance of hepsin and HMGB1 proteins in cervical carcinomaOver-expression of the overexpressed in lung cancer 1 is associated with poor prognosis in epithelial ovarian cancer.LAPTM4B gene polymorphism and endometrial carcinoma risk and prognosis.Correlation of LAPTM4B polymorphisms with gallbladder carcinoma susceptibility in Chinese patients.Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma
P2860
Q34077924-8581F372-801E-49F2-969B-27DE39BF478AQ34235524-1CD5F23A-18AD-482C-8C0F-C9460A899C0AQ34416241-FAC059CF-B964-43E0-AE75-93AE50D33E45Q34416440-C5C77A92-DEBA-4F9D-AA03-FD834D15DC0AQ35092377-30009A7E-5B2A-4640-8498-C0981096B272Q35596871-D6B00808-D973-49F0-B71E-667C3404CFC8Q35679014-C6CEF68F-6045-42FF-931D-43030E2F67CFQ37317324-8237327B-B562-47CB-9C1F-267E6F65D034Q37395811-C95A615A-42ED-4DA7-8B29-AAE227E95B9AQ37510652-CF63D9A0-2E4E-4ADE-A986-DF4BE398AB16Q37636606-34F8AC1F-F7F3-4522-8D81-954FBE10A901Q38715393-150DD27D-F10A-4320-BC58-2C759B2341DFQ38845980-2BD93BDC-36E5-4EBE-B81F-D64AF6328CFCQ40978463-4BE3C062-5529-44E5-9DF7-92A00301C646Q44158296-944BD963-0362-4FC8-B649-5E9D06633C64Q45121136-7658AE4C-871C-4F9F-BD77-AC24C168802DQ46729378-DA965B04-35C1-4B6B-93F4-2A93DCBCF4ACQ57817523-2E77DF53-67BB-4C7A-873E-E9A0B7376B7E
P2860
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@en
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@nl
type
label
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@en
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@nl
prefLabel
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@en
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@nl
P2093
P2860
P356
P1476
LAPTM4B overexpression is a novel predictor of epithelial ovarian carcinoma metastasis.
@en
P2093
Fanling Meng
Haiyu Zhang
Mingzhu Yin
Rouli Zhou
P2860
P304
P356
10.1002/IJC.25689
P577
2010-11-28T00:00:00Z